Proscia has raised a $37 million Series C from investors including Highline Capital Management, Triangle Peak Partners and Alpha Intelligence Capital. The Philadelphia-based company, which is working to digitize pathology research, has now raised around $72 million in total funding.
Featured Story:
Latest Articles
October 1, 2024